Back to School: How biopharma can reboot drug development. Access exclusive analysis here

July 12 Preclinical Quick Takes: Feng Zhang develops latest RNA editing platform, plus tools from David Liu and NIH

Zhang's RESCUE platform converts RNA C to U bases
Feng Zhang and colleagues at Massachusetts Institute of Technology and the Broad Institute of MIT and Harvard have

Read the full 260 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers